Items Tagged ‘#Dr. Julie Allickson’
November 27, 2023
Mayo Clinic seeks to harness the power of cells, tissue and genes by delivering first-of-their kind therapeutics for patients in early-stage clinical trials. Mayo Clinic’s Center for Regenerative Biotherapeutics is leading an effort that is at the crossroads of biology, engineering, industry and medicine to expand biomanufacturing for rare and complex disorders. Biomanufacturing is the […]
Tags: #biologics, #Dr. Cynthia Wilkins, #Dr. Julie Allickson, #Dr. Snigdha Rai, #Immunotherapies, #Mayo Clinic Center for Regenerative Biotherapetics
October 11, 2023
Mayo Clinic prepares to biomanufacture a new CAR-T cell therapy for B-cell blood cancers
Mayo Clinic research has developed a new type of chimeric antigen receptor-T cell therapy (CAR-T cell therapy) aimed at killing B-cell blood cancers that have returned and are no longer responding to treatment. This pioneering technology, designed and developed in the lab of Hong Qin, M.D., Ph.D., killed B-cell tumors grown in the laboratory and […]
Tags: #B-cell blood cancers, #Biomanufacturing, #CAR T-cell therapy, #Dr. Hong Qin, #Dr. Julie Allickson, #Mayo Clinic Center for Regenerative Biotherapeutics
May 31, 2023
Mayo Clinic regenerative biotherapeutics showcased at international conference
Mayo Clinic physicians and scientists are sharing their expertise in regenerative biotherapeutics at a global conference in Paris this week. The International Society for Cell and Gene Therapy (ISCT) conference, Celebrating Progress, Building the Future, is bringing together roughly 2,000 people from around the world that work in industry, academia, government and health care. Together […]
Tags: #Dr. Abba Zubair, #Dr. Allan Dietz, #Dr. Burcin Taner, #Dr. David Lott, #Dr. Julie Allickson, #Dr. Prathibha Varkey, #Dr. Richard Hayden, #Dr. Timothy Nelson, #Dr. Wenchun Qu, #Dr. Yi Lin, #International Society for Cell and Gene Therapy
April 3, 2023
Pivoting toward a new strategy for fighting disease
The Mayo Clinic Symposium on Regenerative Medicine & Surgery 2023 opened today with a look at how biotherapeutics is shaping the future of medicine. “Our commitment to delivering new cures for unmet conditions is behind Mayo’s pivot to biomanufacturing,” says Julie Allickson, Ph.D., the Michael S. and Mary Sue Shannon Family Director of Mayo Clinic’s […]
Tags: #Biomanufacturing, #biotherapeutics, #cell therapies, #Dr. Julie Allickson, #gene therapies, #Mayo Clinic Center for Regenerative Biotherapeutics, #Mayo Clinic Symposium on Regenerative Medicine and Surgery
December 19, 2022
Aspiring to deliver new cures for complex conditions
Mayo Clinic is building toward a future when biologics can cure cancer, kidney disease and diabetes. Mayo marks 2022 as a year of significant strides in accelerating science to make and deliver regenerative biotherapeutics. The goal is to offer new options, based on rigorous research in cell and gene therapies, for disorders with few available […]
Tags: #biologics, #Biomanufacturing, #cell therapy, #Dr. Julie Allickson, #Mayo Clinic Center for Regenerative Biotherapeutics, CAR-T cell therapy
September 27, 2022
Julie Allickson, Ph.D. on Mayo Clinic Q&A Podcast
Through research, clinical trials and biomanufacturing, Mayo Clinic’s Center for Regenerative Biotherapeutics is working to develop new types of medicines derived from the human body to treat chronic and age-related diseases. Biologics are therapies that come from human sources — cells, blood, enzymes, tissues, genes or genetically engineered cells — for use in medicines. Biomanufacturing is focused on […]
Tags: #3D printing, #Biomanufacturing, #Cancer, #cell therapy, #Dr. Julie Allickson, #gene therapy, #Mayo Clinic Center for Regenerative Biotherapeutics
August 30, 2022
A new name for Center for Regenerative Medicine
Mayo Clinic’s Center for Regenerative Medicine has been renamed the Center for Regenerative Biotherapeutics. The name change reflects Mayo’s new strategic focus: manufacturing next-generation biotherapeutics for patients. The new name emphasizes how regenerative medicine at Mayo Clinic has evolved to advance groundbreaking discoveries toward curative products — biotherapeutics — for patients. The Center for Regenerative […]
Tags: #Biomanufacturing, #Dr. Julie Allickson, #Mayo Clinic Center for Regenerative Medicine
August 15, 2022
Mayo Clinic announces a strategic collaboration for a new era of biomanufacturing
Mayo Clinic today announced a strategic collaboration in biomanufacturing to deliver novel biotherapeutics for rare and complex conditions. The collaboration brings together science, engineering and manufacturing to advance Mayo Clinic’s vision of bringing new cures to clinical care. The focus will be on therapies derived from human sources known as biologics — cells, blood, enzymes, […]
Tags: #biologics, #cell therapy, #Dr. Julie Allickson, #gene therapy, #Mayo Clinic Center for Regenerative Medicine, #National Resilience Inc.
July 11, 2022
Bringing regenerative technology of the future to patients today
“The sky’s the limit,” “possibility” and “potential cure for disease” are aspirational ways Mayo Clinic physicians and scientists described regenerative medicine in a recent virtual presentation at the World Stem Cell Summit 2022. Mayo’s panel discussion showcased how it is advancing regenerative medicine through industry collaborations that accelerate scientific discoveries to early stage clinical trials. […]
Tags: #Dr. Abba Zubair, #Dr. David Lott, #Dr. Julie Allickson, #Dr. Saranya Wyles, #Mayo Clinic Center for Regenerative Medicine, #World Stem Cell Summit
June 27, 2022
Biomanufacturing 101: Understanding a new era of therapeutics
Advancing cellular discoveries from clinical trials to commercial therapy is a cornerstone of Mayo Clinic’s strategic emphasis on biomanufacturing. The long-term vision is to provide new cures for patients with unmet needs. “Biomanufacturing is a type of manufacturing that utilizes sources from the human body — cells, blood, enzymes, tissues, genes or genetically engineered cells […]
Tags: #biologics, #biotherapeutics, #Dr. Julie Allickson, #Mayo Clinic Center for Regenerative Medicine, #stem cell research